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Abstract
Activation of the IkB kinase (IKK) is central to NF-kB signaling. However, the precise activation mechanism by which catalytic
IKK subunits gain the ability to induce NF-kB transcriptional activity is not well understood. Here we report a 4 A˚ x-ray
crystal structure of human IKK2 (hIKK2) in its catalytically active conformation. The hIKK2 domain architecture closely
resembles that of Xenopus IKK2 (xIKK2). However, whereas inactivated xIKK2 displays a closed dimeric structure, hIKK2
dimers adopt open conformations that permit higher order oligomerization within the crystal. Reversible oligomerization of
hIKK2 dimers is observed in solution. Mutagenesis confirms that two of the surfaces that mediate oligomerization within the
crystal are also critical for the process of hIKK2 activation in cells. We propose that IKK2 dimers transiently associate with one
another through these interaction surfaces to promote trans auto-phosphorylation as part of their mechanism of activation.
This structure-based model supports recently published structural data that implicate strand exchange as part of a
mechanism for IKK2 activation via trans auto-phosphorylation. Moreover, oligomerization through the interfaces identified
in this study and subsequent trans auto-phosphorylation account for the rapid amplification of IKK2 phosphorylation
observed even in the absence of any upstream kinase.
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Introduction
The IkB kinase (IKK) earns this name for its ability to
phosphorylate two serine residues positioned near the N-terminal
end of cytoplasmic IkB inhibitor proteins. IKK activity, which is
induced by multiple cell stress and inflammatory signals and which
quickly leads to ubiquitin-dependent proteolysis of IkB, is central
to the rapid induction of transcription factor NF-kB and the
elevated expression of NF-kB target genes [1,2]. The prototypical
IKK activity purifies from TNF-a–treated cells as a complex
consisting of three necessary subunits: IKK1/IKKa, IKK2/
IKKb, and NEMO/IKKc (referred to in this report as IKK1,
IKK2, and NEMO, respectively) [3–6]. While IKK1 and IKK2
are closely related kinase domain (KD)-containing enzymes,
NEMO is an obligate scaffolding protein that exhibits higher
affinity for IKK2 than IKK1 [6–10]. A catalytically active 700–
900 kDa complex containing all three subunits is the most
abundant form of IKK in stimulated cells. However, both IKK1
and IKK2 homodimers have also been observed [11]. Gene
knockout studies in mice have revealed that the IKK2 subunit is
primarily responsible for inducing NF-kB activity through signal-
dependent phosphorylation of cytoplasmic IkB proteins (IkBa,
IkBb, and IkBe) and p105/NF-kB1 [8,12,13].
Despite the fact that IKK occupies the central position in
brokering cellular responses to diverse stress signals through NF-
kB, the precise biochemical mechanism behind IKK activation
remains incompletely understood. One essential feature of IKK
activation is its phosphorylation at two activation loop serine
residues (S177 and S181 in hIKK2). Mutation of both these
residues to alanine impedes activation while glutamic acid
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substitutions render the kinase constitutively active [4,14]. It has
been shown that K63-linked and/or linear ubiquitin chain
formation is required for IKK activation by some inducers such
as IL-1 and Toll-like receptor agonists [15]. NEMO appears to
link IKK2 to upstream signaling complexes by interacting with a
C-terminal portion of IKK2 and with poly-ubiquitin chains
through its N-terminal and central coiled-coil regions, respectively
[10,16–18]. Moreover, several additional kinases, such as TAK1,
have been implicated in IKK activation [19]. Apart from
phosphorylation by upstream kinases, however, IKK2 auto-
phosphorylation has also been suggested as a means of activating
IKK2 [20]. For example, Xia et al. recently showed that
unanchored poly-ubiquitin chains can promote IKK activation
independent of any upstream kinase [21].
The recently published 3.6 A˚ X-ray crystal structure of a highly
conserved IKKb from Xenopus laevis (xIKK2) revealed for the first
time the domain organization of a catalytic IKK subunit, albeit in
an inactivated form that shed little light on its mechanism of
activation [22]. Here we report the 4.0 A˚ X-ray crystal structure of
Human IKK2 (hIKK2) in a unique open conformation that
presents its KD in a catalytically active conformation. Pairs of
hIKK2 dimers pack against one another throughout the crystal to
generate several crystallographically distinct versions of the same
higher order oligomer. Introduction of mutations within the
surfaces that mediate this oligomerization disrupts hIKK2
activation loop phosphorylation in cells, suggesting that IKK2
activation requires assembly of higher order homo-oligomers for
trans auto-phosphorylation.
Results
The Human IKK2 X-Ray Crystal Structure
We determined the X-ray crystal structure of a nearly full-
length (amino acids 11–669), constitutively active (S177E/S181E)
hIKK2 from a tetragonal space group by molecular replacement
and Deformable Elastic Network (DEN)-assisted refinement
(Figure 1A) [23]. The final model has a crystallographic R-factor
of 26.7% and free R-factor of 29.9% (Table 1). hIKK2 adopts an
elongated shape composed of three distinct folded domains: an N-
terminal KD, a central ubiquitin-like domain (ULD), and a C-
terminal scaffold dimerization domain (SDD) (Figure 1B). The
structures of the individual domains and their relative arrange-
ment closely resemble that observed in the xIKK2 crystal structure
[22]. This is not surprising as the two proteins share 74% sequence
identity throughout the region crystallized (Figure S1).
The KD exhibits all of the sequence and structural features
typical of a functional catalytic KD in its active conformation [24].
Residues from the catalytic loop, the phosphate binding site, and
the magnesium binding loop occupy the positions of an ordered
catalytic center that can catalyze the phosphoryl transfer reaction
(Figure 1C). For example, the K44–E61 pair contributed by beta-
strand b3 and alpha-helix aC is properly oriented to form a salt
bridge, the DFG tripeptide residues of the Mg2+ binding loop
(DLG in IKK2) occupy their ‘‘active’’ positions, the catalytic base
D145 is poised for catalysis, and the beta-sheet formed by strands
b6 and b9 contains three hydrogen bonds, a signature feature of
all active kinases (Figure 1D). Furthermore, the KD within the
hIKK2 crystal structure also exhibits the constellation of buried
hydrophobic residues that form the ‘‘spine’’ of an active protein
kinase (Figure S2) [25].
Comparison of the KD from hIKK2 and xIKK2 reveals
notable differences in their active site conformations. The b6–b9
sheet is shifted in xIKK2 and the conformation of leucine within
the DLG motif is considerably altered. Consequently, the
regulatory hydrophobic spine of xIKK2 is broken. Furthermore,
side chain conformations of several other residues exhibit clear
differences (Figure 1E). It is possible, therefore, that inhibitor
binding by xIKK2 induces conformational changes within the
activation segment that lead to the observed inactivated confor-
mation of the otherwise constitutively active xIKK2 KD.
An extended polypeptide stretch spans amino acid residues 391
and 410, a dimension of roughly 40 A˚, and links the ULD to the
SDD, a C-terminal alpha-helical domain that mediates dimeriza-
tion. The SDD consists primarily of two long alpha-helices (a2s
and a6s), each approximately 115 A˚ in length, that run parallel to
one another and a third alpha-helical segment extending roughly
the same distance to complete the anti-parallel three-helix bundle.
However, this third stretch is discontinuous, being composed of
alpha-helices a3s, a4s, and a5s. It is also the most solvent exposed
of the three long alpha-helical passes.
One of the signature structural features of IKK2 is the
dependence of KD function upon its two more C-terminal
domains [22,26]. The hIKK2 KD contacts the ULD burying
360 A˚2 total surface area. The similarities at their interface and in
their relative orientations in both the xIKK2 and hIKK2
structures suggest that the IKK2 KD and ULD function together
as a single rigid structural and functional unit. The IKK2
structure reveals extensive intramolecular interactions between
the KD–ULD and SDD. Each module buries nearly 1,200 A˚2 of
surface area, involving 11 residues from the KD–ULD and
another 11 from the SDD (Figure 2A,B). In order to assess the
importance of IKK2 interdomain interactions on catalytic
activity, we prepared three double mutant HA-IKK2 transfection
plasmids. Unless indicated otherwise, all hIKK2 mutations
employed in this study were introduced against the background
of the native (S177/S181) sequence. One pair of mutations,
F111A/E112A, targets the KD at its interface with the SDD,
while two others, L389A/F390A and W434A/H435A, map to
the ULD and SDD, respectively. The IKK2 W434A/H435A
mutant exhibited the greatest defects when immunoprecipitated
and assayed for in vitro IkBa phosphorylation activity, while
IKK2 L389A/F390A and F111A/E112A mutants proved only
partially defective (Figure 2C). Although the detailed mechanism
by which interdomain interactions serve to tune kinase activity
and specificity remains to be determined, this experiment
Author Summary
IkB kinase (IKK) is an enzyme that quickly becomes active
in response to diverse stresses on a cell. Once activated,
IKK promotes an array of cellular defense processes by
phosphorylating IkB, thereby promoting its degradation
and liberating its partner, the pro-survival transcription
factor NF-kB; NF-kB is then free to relocate to the nucleus
where it can modulate gene expression. Our X-ray
crystallographic studies on an active version of the human
IKK2 isoform reveal that the enzyme adopts a unique open
conformation that permits pairs of IKK2 enzymes to form
higher order assemblies in which their catalytic domains
are in close proximity. Disruption of IKK2’s ability to form
these assemblies, by introducing changes that interfere
with the surfaces that mediate oligomerization, results in
IKK2 enzymes that are greatly impaired in their ability to
become activated in cells. We propose that after oligo-
merization the neighboring catalytic domains then phos-
phorylate each other as part of the activation process. Our
findings also suggest that targeted small molecules might
disrupt cell survival by blocking IKK2 assembly in cells.
An X-ray Crystal Structure of Human IKK2
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illustrates that disrupting articulation between the three domains
is detrimental for IKK2 function.
The hIKK2 Dimer Interface
The hIKK2 X-ray crystal structure contains six distinct
protomers within the crystallographic asymmetric unit. Each
mediates contact with three neighbors to form a network of
interactions between subunits (Figure 3A). As IKK2 is known to
function as a component of a high molecular weight complexes in
cells and since surfaces of enzymes that participate in crystal
contacts have often later been discovered to mediate physiolog-
ically relevant binding reactions, it is critical to identify whether
the observed interactions between protomers in the hIKK2 crystal
structure are involved in the process of IKK activation in vivo.
The principal interaction that mediates contacts between
hIKK2 protomers in the X-ray crystal structure is created
exclusively by one face of the C-terminal portion of the SDD
(Figure 3B). A series of hydrophobic residues from alpha-helices
a2s and a6s on each protomer pack symmetrically against one
another to form the dimer. This hydrophobic core is further
stabilized by ionic bonds creating an interface that buries roughly
1,250 A˚2 per subunit. Each of six hIKK2 subunits (chains A
through F) in the asymmetric unit participates in this dimer
interface: chain A with F; B with C; D with E. An analogous
surface contributes to the dimer interface observed in the xIKK2
structure. In contrast to the Xenopus model, however, the N-
terminal KD–ULD portions in each of the three hIKK2 dimers
splay apart at a distance of between 39 and 61 A˚ from one
another.
Overlay of the three hIKK2 dimers reveals near perfect
superposition at the distal portion of the SDD where the two
subunits associate (Figure 3C,D). Similarly, superposition of
hIKK2 (chains A and F) upon the xIKK2 dimer confirms that
their dimer interfaces are nearly identical at the distal end of the
SDD but differ significantly at the end more proximal to the KD–
ULD (Figure 3E). The difference can be attributed to a hinge-like
movement within the SDD near residue G525 between alpha-
helices a4s and a5s. This pivot point allows the more N-terminal
portions of hIKK2 to swing away from one another. Residues that
are observed to mediate dimerization more proximal to the KD–
ULD portion in the xIKK2 structure are primarily polar/charged,
suggesting that this segment might be able to alter its conformation
from the nearly parallel closed conformation observed in the
xIKK2 crystal structure to the open conformation of hIKK2
(Figure 3F).
As the dimer interface within the distal portion of the SDD is
common to all the dimers in both the hIKK2 and xIKK2
structures, it can be concluded with some certainty that both
enzymes dimerize through this region. Xu et al. have validated the
functional importance of this interface in constitutively active
(S177E/S181E) human IKK2 by preparing enzymes with pairs of
mutations that disrupt dimerization and finding that they are
primarily monomeric in solution [22]. We further tested the
functional consequences of destabilizing this region by altering
three pairs of residues (W655D/L658D, L654D/W655D, and
K482A/F485D) in human IKK2 (native activation loop sequence)
and measuring the kinase activity of these mutant enzymes in
vitro. After HA–IKK2 native and mutant proteins were immu-
noprecipitated from transfected HEK293T cells, a significant
decrease in IKK2 catalytic activity was observed in the mutants
(Figure 3G). These results suggest that amino acid residues from
the SDD that mediate the dimer interface are important in hIKK2
activation and/or IkBa phosphorylation.
Higher Order hIKK2 Assembly
A close inspection of the arrangement of hIKK2 within the
crystal reveals that individual dimers stack upon neighbors to form
a continuous repeating oligomeric chain (Figure 4). Oligomeriza-
tion results from the asymmetric interaction of neighboring dimers
such that the N-terminal KD–ULD portions and proximal SDD of
two protomers interact to form a bent ‘‘V-shaped’’ interface, while
the other two protomers rest next to one another in a nearly
antiparallel arrangement involving the KD, ULD, and central
portion of the SDD. Slight variations in these interfaces, due likely
to the influence of crystal packing forces, introduce small breaks in
the otherwise continuous chain of similarly stacked dimers. This
results in a crystal composed of four distinct but structurally similar
‘‘tetramers’’ (chains F-A-B-C, B-C-D-E, D-E-E9-D9, and A0-F0-F-
A, where the prime and double-prime symbols indicate chains
from two different neighboring asymmetric units), while the
fundamental asymmetric unit of the crystal contains three hIKK2
homodimers (Figure 4B). A significant portion of the hIKK2
surface is involved in mediating its oligomerization with its
Figure 1. The hIKK2 X-ray crystal structure. (A) Domain
organization schematics of full-length hIKK2 (above) and crystallized
protein construct (below). The KD, ubiquitin-like domain (ULD), scaffold
dimerization domain (SDD), and NEMO-binding region (N) are indicated
and the domain borders are numbered. ‘‘EE’’ represents mutation of
two active site serines 177 and 181 to glutamic acid residues in the
crystallized protein. (B) Ribbon diagram representation of the hIKK2 X-
ray crystal structure. Coloring and labels correspond to part A.
Individual helices of the SDD are labeled as are the N and C termini
(N and C, respectively). (C) Ribbon diagram representation of the hIKK2
KD with secondary structure elements and key amino acid side chain
positions labeled. (D) Close-up view of the structural elements and
amino acid residues immediately surrounding the activation loop (blue).
(E) Superposition of hIKK2 (green) and xIKK2 (brown) KDs depicted in
Ca-trace representation. Several amino acid residues that adopt
significantly different positions in the two structures are rendered as
sticks (yellow for hIKK2; orange for xIKK2) and labeled.
doi:10.1371/journal.pbio.1001581.g001
An X-ray Crystal Structure of Human IKK2
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neighbors in the crystal. The V-shaped interfaces (calculated from
chains F-A-B-C, B-C-D-E, and D-E-E9-D9) bury roughly 2,000 A˚2
of solvent exposed surface area on average, while each antiparallel
interface (calculated from chains F-A-B-C, B-C-D-E, and A0-F0-F-
A) excludes nearly 1,200 A˚2.
Prior to solving and refining the hIKK2 crystal structure from
the tetragonal space group, we obtained complete X-ray
diffraction data to 7 A˚ resolution on a constitutively active
(S177E/S181E) hIKK2 construct encompassing amino acids 1–
700 crystallized in a hexagonal space group (Figure S3A).
Molecular replacement using the refined hIKK2EE(11–669)
model as a probe yielded a probable solution to the hexagonal
crystal structure in which open hIKK2 dimers employ their V-
shaped and antiparallel oligomerization interfaces to stack against
crystallographically identical dimers in a continuous linear array
throughout the crystal unit cell (Figure S3B). The crystal packing
for this solution is ideal and maximum likelihood rigid body
refinement of the resulting model against all data between 50 and
7 A˚ results in a significant decrease in R-factors (Table S1).
In light of the common interactions observed to mediate
contacts between molecules in the two hIKK2 crystal forms, we
hypothesized that oligomerization through these surfaces could
play a role in IKK function. In order to test this structure-based
hypothesis, we first investigated whether hIKK2 assembles
spontaneously into higher order oligomers in solution. Analytical
ultracentrifugation sedimentation velocity experiments carried out
on His-tagged full-length hIKK2 identified monomer and dimer
populations. Moreover, peaks corresponding in size to tetramers,
hexamers, and even octamers could also be clearly detected
(Figure 5A). In a separate experiment, size exclusion chromatog-
raphy followed by simultaneous measurement of absorbance,
multi-angle laser light scattering, and refractive index (SEC-
MALLS) to allow for shape-independent molecular weight
determination of hIKK2 pretreated with ATP and concentrated
as for crystallization clearly detected dimers and tetramers
(Figure 5B). The proportion of tetramer to dimer remained
relatively small even as the concentration approached the
solubility limit of the protein, suggesting that spontaneous and
reversible assembly of hIKK2 dimers into higher order oligomers
is a low-affinity process in vitro. SEC-MALLS further revealed
that the double mutation of residues I413 and L414, both of which
reside at the V-shaped interface, to alanine disrupts the smooth
transition of hIKK2 from dimer to tetramer such that significantly
more of the mutant protein elutes as a heterogeneous aggregate
(Figure 5C).
Table 1. Data collection and refinement statistics
Data Collection and Refinement IKK2(11–669)EE
Data collection
X-ray source APS 19ID
Wavelength (A˚) 0.97935
Space group P4122
Unit cell (A˚)
a 170.81
b 170.81
c 509.56
Molecules/asymm. unit 6
Resolution range (A˚)a 30.0–3.98 (4.12–3.98)
Rsym (%) 13.9 (73.6)
Observations 248,094
Unique reflections 63,535
Completeness (%) 96.2 (97.9)
,I/s. 6.3 (2.4)
Refinement
Number of reflectionsb 53,076
Rcryst (%) 26.7 (37.6)
Rfree (%)
c 29.9 (39.3)
Protein atoms 30,060
R.m.s.d.
Bond lengths (A˚) 0.0093
Bond angles (u) 1.08
Ramachandran plot
Favored 65%
Allowed 33%
Disallowed 2%
MolProbity scored 3.40
PDB accession code 4E3C
aData in parentheses are for highest resolution shell.
bReflections with |FO|/s,1.0 rejected.
cCalculated against a cross-validation set of 3.8% of data selected at random
prior to refinement.
dCombines clashscore, rotamer, and Ramachandran evaluations in to a single
score, normalized to the same scale as x-ray resolution [40].
doi:10.1371/journal.pbio.1001581.t001
Figure 2. Domain–domain interactions in IKK2. (A) Close-up view of the ULD–SDD interface. Coloring is consistent with Figure 1. (B) Close-up
view of the KD–SDD interface. (C) In vitro kinase assays in which hIKK2 with mutations that target interdomain interfaces (lanes 3–5) is compared
against the native protein (lane 2).
doi:10.1371/journal.pbio.1001581.g002
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The relatively low-affinity oligomerization observed in vitro
does not preclude the possibility that transient interactions
between hIKK2 dimers might be involved in the transition of
the enzyme from its inactive to active state in vivo. In order to test
whether the oligomerization interfaces observed in the hIKK2 X-
ray crystal structure are critical to its biochemical function, we
next engineered additional mutations aimed at destabilizing either
the V-shaped or antiparallel interfaces and assayed their in vitro
kinase activity after immunoprecipitation from transfected
HEK293T cells (Figure 6). Three hIKK2 double mutants designed
to disrupt the V-shaped interface, P403A/P405A, I413A/L414A,
and P417A/K418A, displayed a significant decrease in their
ability to function as catalysts of IkBa phosphorylation in vitro
relative to native protein or proteins in which residues at the dimer
interface were mutated (Figure 6E). This decreased catalytic
efficiency could result either from disruption of the kinase
phospho-transfer mechanism or by interfering with the ability of
the kinase to become activated. In order to distinguish whether the
V-shaped mutations affect kinase activity or kinase activation, we
next carried out the same assay with hIKK2 constructs in which
the mutations were introduced against the constitutively active
(S177E/S181E) hIKK2 background. These constitutively active
proteins bearing mutations at their V-shaped oligomerization
interface functioned with kinase activity identical to the native
sequence (Figure 6F). Moreover, immunoblot of the hIKK2
proteins bearing mutations only at the V-shaped interface with a
monoclonal antibody raised to specifically recognize phosphory-
lated S177 and S181 on hIKK2 revealed that these activation loop
residues were not phosphorylated upon overexpression (Figure 6G).
These experiments strongly suggest that residues observed to
mediate oligomerization through the V-shaped interface in the
hIKK2 crystal structure are critical in the transition of the kinase
from its inactive to active state. Similar experiments aimed to
assess the role of the antiparallel interface in IKK2 function
indicated that mutations that target this surface do not affect
kinase activation (Figure 6H).
Figure 3. The hIKK2 dimer interface. (A) Ribbon diagram (top) and space filling (bottom) representations of six hIKK2 protomers in the
asymmetric unit. The individual subunit chains are labeled A–F and rainbow colored. (B) Ribbon diagrams of three hIKK2 dimers taken from the
asymmetric unit. The distances between P578 residues from each hIKK2 in the dimers are labeled. For comparison, the xIKK2 crystal structure
observed is shown below in its relatively closed conformation. (C) Overlay of the SDD from six monomers in the hIKK2 asymmetric unit. The three
dimers overlay perfectly at their SDD distal ends (inside dashed box). Movement about a hinge point (black arrowheads) results in the differences
observed in the portions of the SDD more proximal to the KD. (D) A close-up view reveals the series of hydrophobic and ionic interactions that
mediate the dimer interface. (E) Superposition of the A:F dimer SDD from the hIKK2 structure and the xIKK2 dimer. (F) Close-up view of the boxed
region from panel D reveals additional interactions present within the interface of the xIKK2 structure SDD. (G) In vitro kinase assays monitoring the
activity of immunoprecipitated HA-IKK2 toward IkBa. Mutations targeting the dimer interface (lanes 3–5) are compared against the wild-type protein
(lane 2).
doi:10.1371/journal.pbio.1001581.g003
An X-ray Crystal Structure of Human IKK2
PLOS Biology | www.plosbiology.org 5 June 2013 | Volume 11 | Issue 6 | e1001581
KD–KD Interactions of Oligomeric hIKK2
We next wished to investigate the mechanism through which
mutation of residues at the V-shaped interface blocks the transition
of inactive hIKK2 to its active state. One possibility is suggested by
the fact that oligomerization of hIKK2 dimers projects the KDs of
the two subunits interacting through the V-shaped interface away
from its dimer partner in a manner that could support KD–KD
interactions. Indeed, further inspection of the arrangement of
hIKK2 protomers in the crystal reveals that one of the largest
crystal contact surfaces between symmetry-related units within the
crystal occurs between four KDs at two V-shaped interfaces
(Figure 7A). The orientation of the KDs at the V-shaped interface
permits them to approach one another in a manner that brings the
activation loop of one KD within close proximity to the active site
of another, and vice versa. For example, E181 (the mutated
phosphomimetic version of S181) from protomer A is positioned
within only 5 A˚ of E181 from protomer D9 from a neighboring
asymmetric unit in the crystal (Figure 7B,C). Only slight structural
rearrangement would be required for the activation loop serines to
insert into the active site of the opposing subunit for trans auto-
phosphorylation.
In order to test whether these symmetrical KD–KD interaction
surfaces are involved in the process of hIKK2 activation in cells,
we produced mutant enzymes and tested their ability to become
activated through in vitro kinase assays and immunoblot. Two
mutants, V229A/H232A and Y294L/G295K/P296Q, displayed
severe defects in their ability to phosphorylate an IkBa substrate
after transfection and immunoprecipitation from transfected
HEK293T cells (Figure 7D). In the triple mutant, three residues
in hIKK2 at the supposed KD–KD interface were replaced with
corresponding residues from hIKK1, suggesting that the activation
mechanisms of IKK1 and IKK2 may differ. When the same
mutations are introduced against the constitutively active S177E/
S181E background and the resulting proteins are immunoprecip-
itated and assayed, we observe that they function with activity
similar to the constitutively active native enzyme (Figure 7E). In
order to determine whether the observed decrease in kinase
activity of the KD–KD mutant enzymes results from an inability
Figure 4. Oligomerization of hIKK2 dimers in the crystal. (A) Three successive asymmetric units, each composed of six protomers, are taken
from the hIKK2 X-ray crystal structure and depicted with the center asymmetric unit (labeled A–F) and colored with surface rendering as in Figure 3A.
Within this arrangement can be found four unique but closely related versions of the same dimer of dimers. Beginning from the left, there are four
protomers (D, E, and another D9 and E9 from the symmetry-related asymmetric unit) that assemble into a tetramer. These four polypeptide chains are
depicted as opaque, while the remaining protomers are rendered as semitransparent. In the second depiction of the same assembly of three
asymmetric units, chains B, C, D, and E are rendered opaque and reveal themselves to assemble with a similar tetrameric arrangement. Likewise,
protomers A, B, C, and F in the third panel and A, F, and the symmetry-related A0 and F0 chains assemble into renditions of the same tetramer. (B)
Close-up views of the four unique assemblies viewed perpendicular to their 2-fold rotation axes reveal their close similarity.
doi:10.1371/journal.pbio.1001581.g004
Figure 5. Evidence for oligomerization of hIKK2 dimers in solution. (A) Analytical ultracentrifugation sedimentation velocity experiments on
concentrated samples of full-length hIKK2 reveal a pattern that correlates with monomer–dimer equilibrium as well as formation of tetramers,
hexamers, and octamers in solution. Arrows mark peaks and a summary of data output including calculated molecular weights is inset. (B) When full-
length, ATP-treated hIKK2 is analyzed by SEC-MALLS, one observes peaks that correspond to dimer (major peak) and tetramer (minor peak). (C) The
hIKK2 I413A/L414A mutant protein displays defects in its ability to undergo reversible dimer–tetramer transitions without aggregating.
doi:10.1371/journal.pbio.1001581.g005
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to adopt their active state, the phosphorylation status of transfected
hIKK2 enzymes was probed by immunoblot with antipho-
sphoserine 177/181 antibody. Both KD–KD mutants displayed
extremely low levels of activation loop phosphorylation relative to
the native enzyme (Figure 7F). These experiments suggest that the
surfaces observed to mediate KD–KD interactions in the hIKK2
crystal structure are necessary for trans auto-phosphorylation
within the activation loop in cells. Interestingly, such a mechanism
is supported by the recently published high-resolution X-ray
crystal structure of the KD–ULD portion of the IKK-related
TANK-binding Kinase 1 (TBK1). In that crystal structure,
activation loop amino acids 164–199 of one TBK1 KD were
repositioned such that the critical Ser172 phosphorylation site had
entered the active site of the neighboring kinase [27].
In support of a mechanistic model whereby IKK2 becomes
activated through oligomerization-dependent trans auto-phosphor-
ylation, we next investigated whether IKK2 trans auto-phosphor-
ylation could be reconstituted in vitro. To this end, we expressed
and purified a C-terminally truncated version of hIKK2 in which
the catalytic D145 residue was mutated to asparagine. The
resulting protein is incapable of supporting phosphoryl group
transfer, but can be phosphorylated on its activation loop serine
residues. Immunodetection with an antibody specific for phos-
phorylated S181 of IKK2 confirmed that this mutant enzyme
could be phosphorylated in trans on its activation loop upon
incubation with native full-length hIKK2 enzyme and Mg-ATP
(Figure 8).
The Influence of NEMO on IKK2 Oligomerization
Our structure-based biochemical analyses suggest oligomeriza-
tion-dependent trans auto-phosphorylation as a mechanism by
which IKK2 can switch from its inactive form to a state of catalytic
activity. Such a mechanism demands that there exist some manner
of regulation to keep auto-phosphorylation from occurring
constantly. We propose that fine regulation of IKK2
homo-oligomerization is part of the function of the obligatory
IKK subunit NEMO. The IKK2–NEMO interaction has been
well studied in vitro and in transfection systems [16,20,28].
Binding occurs at cellular steady state and requires small segments
from the N-terminal portion of NEMO and the C-terminal
NEMO-binding region of IKK2. Moreover, it has been widely
believed that IKK2 switches from a low to a high molecular weight
species upon cell stimulation.
In an effort to observe whether NEMO controls higher order
oligomerization of IKK2, we carried out size exclusion fraction-
ation of endogenous and transfected IKK2–NEMO complexes.
Surprisingly, our studies of IKK2 oligomerization in cells disagree
with the popularly held view. We observe that endogenous cellular
IKK2–NEMO complexes elute at a high molecular weight both
before and after TNF-a stimulation (Figure 9A). Moreover,
transfected IKK2–NEMO complexes also exhibit comparably
high molecular weight upon fractionation by size exclusion
chromatography (Figure 9B).
Discussion
Oligomerization in the Process of IKK2 Activation
Our crystallographic and structure-based biochemical analyses
of hIKK2 in its catalytically active conformation points to a model
for kinase activation wherein dynamic association and dissociation
of hIKK2 subunits occurs through multiple interfaces (Figure 10A).
The predominant surface involved in association of individual
IKK2 subunits is the distal SDD that mediates dimerization.
Flexibility within the SDD permits a transition from the closed
dimeric conformation observed in the xIKK2 crystal structure to
the open conformation observed in hIKK2. This change in
conformation is important as the active sites of two neighboring
KDs cannot approach one another in the closed conformation
without the two molecules clashing. In light of the fact that the
hIKK2 KD exhibits an active conformation while the otherwise
Figure 6. Oligomerization of hIKK2 dimers. (A) Ribbon diagram of the interaction between two neighboring hIKK2 dimers in the crystal. Their
asymmetric association gives rise to two unique intersubunit interfaces. (B) Close-up view of residues that interact between the KDs at the V-shaped
interface. (C) Additional residues that mediate V-shaped interface interactions between the ULD an SDD. (D) Close-up view of interacting residues
within the anti-parallel interface. (E) In vitro kinase assay reveals that catalytic activity of hIKK2 with mutations that disrupt the V-shaped interface
(lanes 3–5) is drastically reduced compared to wild-type protein (WT-lane 2). (F) In vitro kinase assays with the same WT mutant proteins in which
activation loop serines are mutated to glutamate. (G) Immunoblotting with anti-phospho-Ser177,181 antibody reveals that the decrease in catalytic
activity observed in the V-shaped interface mutants correlates with activation loop phosphorylation status. (H) In vitro kinase assays reveal the
modest effects on hIKK2 catalytic activity of mutation at the antiparallel interface.
doi:10.1371/journal.pbio.1001581.g006
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constitutively active xIKK2 KD was crystallized bound to a small
molecule inhibitor compound, it is tempting to speculate that the
transition between these two extreme dimeric conformations is
linked to the activation state of the kinase. However, two recently
published reports on X-ray crystal structures of the IKK-related
protein TBK1 show that both active and inactive forms crystallize
in varying degrees of the closed conformation [29,30]. This
suggests that the switch between open and closed conformation is
transient even at concentrations of protein high enough to support
crystal formation.
Additional portions of the IKK2 molecular surface are
necessary for its activation as indicated by our structure-based
cellular assays. One involves a face of the KD–ULD together with
a central portion of the SDD to mediate the V-shaped interaction.
Another is a broad region on the KD proximal to the activation
loop that supports KD–KD interactions within the crystal.
Combining these observations with those obtained previously
from structural and biochemical investigation into xIKK2 leads to
the emergence of a new structure-based mechanism for the
conversion of IKK2 from inactive dimer to functioning kinase
(Figure 10B). In this model, dimeric IKK2 alternates between
closed and open conformations in the cell. Oligomerization of
open IKK2 dimers through the V-shaped interaction observed in
the X-ray crystal structures serves to stabilize the enzyme in a
conformation that permits transient homotypic interactions
through the IKK2 KD to support trans auto-phosphorylation
(Figure S4).
This IKK2 oligomerization hypothesis helps explain the
difficulty researchers have experienced in identifying a single
upstream IKK2 kinase responsible for activating IKK2 by
phosphorylating its activation loop S177 and S181 residues.
Moreover, transient oligomerization of IKK2 in a conformation
that promotes trans auto-phosphorylation would naturally direct
and amplify the activity of any signaling kinase functioning directly
upstream of IKK2 to quickly generate a pool of catalytically active
IKK2, consistent with the rapid amplification of IKK2 phosphor-
ylation that is observed in vivo. Finally, our discovery that the
Figure 7. Interaction between KDs of oligomeric hIKK2. (A) Within the crystal, neighboring tetrameric assemblies interact symmetrically such
that they contact one another through their V-shaped interfaces and two KDs are positioned within close proximity to one another (dashed box). (B)
The close packed KDs are positioned so that their activation loops (dashed box) rest directly over the active site of a neighbor. Orange spheres mark
the Ca positions on V229 and H232. (C) Close-up view of the kinase activation loops (yellow and blue) with glutamic acid residues 177 and 181
mimicking activation loop serines and the catalytic base D145 labeled. (D) In vitro kinase assay on immunoprecipitated hIKK2 with mutations at key
residues that mediate KD–KD interactions in the crystal (lanes 3,4) reveals their involvement in catalytic activity. (E) Mutation of activation loop serines
177 and 181 to glutamates restores activity of immunoprecipitated IKK2 in vitro. (F) Immunoblotting with anti-phospho-Ser177,181 antibody reveals
that the decrease in catalytic activity observed in the KD–KD interface mutants correlates with decreased activation loop phosphorylation.
doi:10.1371/journal.pbio.1001581.g007
Figure 8. In vitro reconstitution of hIKK2 trans auto-phosphor-
ylation. A catalytically inactive (D145N) and C-terminally truncated
IKK2 (lanes 1–6) and mixtures of that enzyme with a catalytically active
full-length version (lanes 4–6) were incubated with Mg-ATP for the time
periods indicated and then probed via Western blot with anti-
phosphoSer181 antibody (above) or by SDS PAGE (below).
doi:10.1371/journal.pbio.1001581.g008
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introduction of mutations within the oligomerization interfaces
observed in the hIKK2 X-ray crystal structure is sufficient to
disrupt activation suggests that small molecules designed to
interfere with oligomerization through these interfaces should
function as specific inhibitors of IKK2.
The Integral Role of NEMO in IKK Activation
The biggest questions that remain regarding IKK2 activation
involve the fundamental role played by NEMO. It has been clearly
demonstrated that NEMO is central to NF-kB activation in
response to classical pro-inflammatory stimuli [31]. Contrary to
published reports, our data suggest that endogenous IKK2–
NEMO complexes do not undergo a significant change in size
upon TNF-a stimulation of cells. It is possible that difficulties in
accurate measurement of IKK complex size are simply due to the
elongated coiled-coil nature of NEMO, which consequently runs
as a high molecular weight independent of IKK activation state
and even when transfected and overexpressed relative to IKK2.
However, an even greater problem appears to be the misinter-
pretation of published experimental data that clearly show a sharp
increase in kinase activity, though not necessarily the molecular mass, of
the high molecular weight IKK complex fraction upon stimulation
of cells with pro-inflammatory stimuli.
The absence of a significant shift in molecular weight of the
IKK2–NEMO complex upon cell stimulation and kinase
activation suggests that IKK2 interaction through the oligomer-
ization interfaces identified in our X-ray crystal structures is
transient in nature. We propose that association with NEMO
primes IKK2 so that it can become readily activated in response
to early signaling events including receptor-mediated signalsome
assembly and poly-ubiquitin chain formation. The precise
mechanism by which NEMO prepares IKK2 for activation
remains unclear, though it is apparently passive as the ability of
NEMO to interact with IKK2 remains unchanged throughout
the process of NF-kB induction. It is apparent, however, that the
dependence upon NEMO for IKK2 activation can be circum-
vented by increasing the IKK2 concentration either in vitro or by
its overexpression in transfected cells. This is why transfected
IKK2–NEMO complexes are active while endogenous IKK2–
NEMO remain inactive unless first induced by a pro-inflamma-
tory stimulus [32]. We suggest that early signaling events
involving poly-ubiquitin chains allow NEMO to permit rapid,
transient oligomerization of IKK2, which leads directly to
activation of the kinase catalytic activation via trans auto-
phosphorylation. Such rapid binding and dissociation could then
allow IKK2 activity to become amplified efficiently through
activation loop trans auto-phosphorylation of neighboring tran-
sient assemblages. This model agrees well with a recently
published report that free poly-ubiquitin chains can induce
IKK activation via trans auto-phosphorylation [21]. NEMO also
plays additional roles in facilitating NF-kB activation, such as by
directing IKK2 catalytic activity toward IkBa via interaction with
the NF-kB inhibitor through its C-terminal zinc finger domain
[33].
Materials and Methods
Plasmids, Oligonucleotides, and Cell Lines
The full-length hIKK2 cDNA clone was graciously provided by
Y. Chen and the laboratory of M. Karin. For large-scale
purification and in vitro biochemical assays, full-length human
IKK2 was cloned in pFastBacHTb (Invitrogen) vector within
BamHI and NotI sites giving rise to an N-terminal hexa-Histidine
tag followed by TEV protease recognition sequence. Codons
corresponding to S177 and S181 were mutated to E by the
Quickchange mutagenesis protocol (Agilent) to generate the
hIKK2EE clone. The hIKK2EE 1–700 construct was created
by mutating hIKK2 amino acid 701 to a stop codon. Gene
fragments corresponding to hIKK2EE 11–669 and 11–700 were
amplified by PCR and subcloned into pFastBacHTb. For cellular
assays, hIKK2 was cloned as a HA-tagged version into pRC or
pCMV-HA (Clontech) vector. For ex vivo cellular biochemistry
assays, HA-IKK2 constructs were transfected into HEK293T cells
using Lipofectamine 2000 (Invitrogen) reagent following the
manufacturer’s protocol. All oligonucleotides were purchased
from IDT. Restriction enzymes and T4 DNA ligase were procured
from New England Biolabs.
Protein Expression and Purification
Recombinant virus production and protein expression were
performed with modifications of a previously published protocol
[26]. Sf9 suspension cultures were infected with baculoviruses at a
cell density of 26106/mL and allowed to grow for 48–72 h
postinfection. Cells were harvested and lysed in Lysis buffer
(25 mM Tris pH 8.0, 200 mM NaCl, 10 mM imidazole, 10%
Glycerol, 5 mM b-Mercaptoethanol, and protease inhibitor
cocktail) by sonication. The lysate was clarified by centrifugation
at 14,000 rpm for 45 min at 4uC and loaded onto Ni-NTA resin
(Qiagen). The resin was thoroughly washed with Lysis buffer
containing 30 mM Imidazole prior to elution using the same
buffer with 250 mM imidazole. Peak fractions were pooled and
Figure 9. Size exclusion chromatography of endogenous and
transfected IKK complexes. (A) Cytosolic extracts of untreated
(above) and treated (below; 10 ng/mL of TNF for 10 min) MEF-3T3 cells
were loaded onto a Superose 6 HR size exclusion column and
fractionated at a flow rate of 0.5 mL/min. Fraction size was 0.5 mL.
Fractions, as shown in the figure, were resolved on 10% SDS-PAGE and
probed with anti-IKK2 and anti-NEMO antibodies. The experiment was
performed at least thrice and representative blots are shown here. (B)
HEK293T cells were transfected with HA-IKK2 (above), HA-IKK2 and
NEMO (middle), or NEMO alone (below) and lysates were separated by
size exclusion chromatography and probed by anti-HA or anti-NEMO
antibodies.
doi:10.1371/journal.pbio.1001581.g009
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treated with TEV protease to remove the His-tag. The protein was
then incubated with 1 mM ATP in presence of 20 mM MgCl2,
20 mM b-glycerophosphate, 10 mM NaF, and 1 mM sodium
orthovanadate for 1 h and loaded onto preparative Superdex200
size exclusion column connected to an A¨KTA purifier (GE
Healthcare) equilibrated with 20 mM Tris-HCl (pH 8.0), 150 mM
NaCl, 5 mM DTT, 5% glycerol. Peak fractions were concentrated
by centrifugation using 30 kDa cutoff membrane concentrator
unit (Millipore). Protein concentration was determined using
Bradford reagent (BioRad) and was snap frozen in liquid N2 for
long-term storage at 280uC. GST-IkBa1-54 was purified from E.
coli BL21(DE3) cells using Glutathione-Sepharose (GE Healthcare)
resin.
Crystallization
Both crystal forms were obtained by hanging drop vapor
diffusion method. Protein sample was mixed with Inhibitor
MLN120B (Millennium Pharmaceuticals) at a molar ratio of 1:2
and incubated for 30 min. We combined 1 mL of protein–inhibitor
mixture with an equal amount of reservoir solution containing 1.5
to 2 M sodium malonate pH 6.0, 0.3–0.5 M ammonium acetate,
and 10 mM DTT and equilibrated over the same solution at 18 or
20uC. Hexagonal crystal appeared within 2–3 d and grew to
maximum dimension of 506506400 mm within 10–14 d. The
crystals were frozen in liquid N2 using well solution containing
25%–30% Glycerol or 2.5 M sodium malonate as cryoprotectant.
Tetragonal crystals were obtained by mixing equal volumes of
protein–inhibitor complex with 1.0–1.3 M sodium malonate
pH 6.5, 0.2–0.4 M Ammonium acetate, and 10 mM DTT and
equilibrating the drop over the same solution at 18uC. Crystals
appeared in 15 d and took nearly a month to grow to a final size of
up to 706706250 mm. Crystals were cryo-preserved in a similar
fashion mentioned above and stored in liquid N2 prior to data
collection.
X-Ray Diffraction Data Collection
X-ray diffraction data were collected on a Quantum 315 CCD
detector (ADSC) at the Advanced Photon Source synchrotron
beamline 19ID at Argonne National Laboratory. The hexagonal
crystal form gave strong diffraction patterns that failed to extend
beyond 6.95 A˚ resolution. The diffraction pattern of the tetragonal
crystal extended to 4 A˚ and revealed that the crystal belongs to
space group P4122 or P4322 with unit cell: a = b = 170.81,
c = 509.56 A˚. Diffraction intensities were indexed, integrated,
and scaled using HKL2000 [34]. Data collection statistics are
summarized in Table 1 and Table S1.
Structure Solution
Due to data quality and resolution and the presence of multiple
molecules in the asymmetric unit, molecular replacement proved
challenging. Initially, a brute force molecular replacement strategy
was employed in which more than one hundred different IKK2
tetramer, dimer, or monomer models were generated manually
based on the xIKK2 structure and used as search probes in various
software packages. One of these test models identified two pairs of
closely packed protomers (chains A:B and C:D) in space group
P4122 using the CCP4 program MOLREP [35]. With the A:B
and C:D dimers fixed, one rigid-body refined monomer was then
used as search model in MOLREP to identify the position of chain
E, which participates in a similar interaction with its own
symmetry related partner along a 2-fold axis. Crystal packing
and electron density map calculation from this initial model
indicated that there were likely additional molecules in the
asymmetric unit but molecular replacement failed to locate them.
Figure 10. IKK2 oligomerization activation model. (A) The hIKK2 X-ray crystal structure in space filling representation viewed from three
different angles. The four surfaces that mediate oligomerization in the X-ray crystal structure are colored purple (dimer interface), blue (antiparallel
interface), orange (V-shaped interface), and green (KD–KD interface). (B) A structure-based model for IKK2 activation via trans auto-phosphorylation.
IKK2 interconverts between its open and closed dimeric forms. The open dimer can further associate to form transient homooligomers, such as
observed in the hIKK2 X-ray crystal structure. Phosphorylation of one IKK2 subunit by an upstream kinase activates the kinase activity of that subunit
and, as a consequence of its propensity to assemble into higher order oligomers through it V-shaped and KD-KD interfaces, is rapidly amplified via
trans auto-phosphorylation.
doi:10.1371/journal.pbio.1001581.g010
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The initial position of the sixth molecule, monomer F, was
obtained by rotating monomer E about the 2-fold pseudo-
symmetry axis relating the A:B and C:D V-shaped dimers.
Refinement and crystal packing confirmed this to be the correct
position for the sixth IKK2 subunit in the asymmetric unit. With
six molecules in the asymmetric unit, the calculated solvent
volume in the crystal is 64%.
Model Building and Refinement
The orientation and position of the initial model containing six
IKK2 chains were refined by rigid-body refinement followed by
minimization and simulated annealing refinement with a maxi-
mum likelihood target function and a flat bulk-solvent correction
using the CNS system version 1.1 [36]. Model rebuilding was
carried out using 2FO-FC electron density maps in XTALVIEW
[37]. Due to the relatively low resolution data used throughout
refinement, upon refinement of the model to R-factors of 27.5%
(R-cryst) and 36.6% (R-free), CNS version 1.3 was employed in
order to carry out Deformable Elastic Network (DEN)–assisted
refinement [23]. Initially, coordinates from a rigid-body refined
xIKK2 model were employed as a reference. After a few
refinement cycles with application of strict NCS restraints, the
hIKK2 exhibited better model geometry than the reference
structures and the chain with the best geometry among the six
molecules was used to direct building and refinement of the final
crystallographic model. DEN refinement dramatically improved
the geometry and R-factors of the hIKK2 structure to a final R-
cryst of 26.7% and R-free of 29.9%. Detailed refinement statistics
are included in Table 1. Coordinates and structure factors for the
hIKK2(11-669)EE crystal structure have been deposited into the
Protein Data Bank as entry code 4E3C [38]. Model figures were
made in PyMOL [39].
Immunoprecipitation and Kinase Assay
Following transfection, HEK293 cells were grown for 24 h
before harvesting and lysing in RIPA buffer supplemented with 16
phosphatase inhibitor cocktail (Sigma). HA-IKK2 was immuno-
precipitated by adding 1 mg of anti-HA antibody (Covance,
16B12) to each pre-cleared cell lysate and incubated for 2 h at
4uC, and protein G sepharose (GE Healthcare) was subsequently
added to each sample and allowed to bind for another 1 h at 4uC
with mixing. Beads were then precipitated and washed rigorously
using the cytoplasmic extraction buffer (10 mM HEPES–KOH
pH 7.9, 250 mM NaCl, 1 mM EDTA, 0.5% NP-40, 0.2% Tween
20, 2 mM DTT, 1 mM PMSF, 20 mM b-glycerophosphate,
10 mM NaF, 0.1 mM Sodium orthovanadate). Beads were
washed with kinase assay buffer (20 mM HEPES–KOH pH 7.7,
100 mM NaCl, 10 mM MgCl2, 2 mM DTT, 20 mM b-glycero-
phosphate, 10 mM NaF, 0.1 mM Sodium orthovanadate, 20 mM
ATP) without ATP prior to kinase assay. Kinase assay was
performed with immunoprecipitated IKK2 using GST-IkBa (1–
54) as the substrate in presence of 10 mCi c-32P-ATP at 30uC for
30 min. Kinase reactions were stopped by boiling with 16
Laemmli buffer and resolved on 10% SDS-PAGE. The gel portion
containing radioactive substrate was excised and detected by
autoradiography. The portion containing IKK2 was transferred to
nitrocellulose membrane and probed with anti-HA antibody.
Analytical Ultracentrifugation
Full-length His-tagged IKK2 and IKK2EE(11–669) were
purified and prepared as previously described. Sedimentation
velocity (SV) experiments were performed in a ProteomeLab XL-I
(BeckmanCoulter) analytical ultracentrifuge. Protein samples were
loaded at a concentration of ,0.5 mg/ml in two-channel cells and
spun in an An-50 Ti 8-place rotor at 30,000 rpm, 20uC for 15 h.
Data were analyzed using Sedfit software (P. Schuck, NIH/
NIBIB).
SEC-MALLS
Full length His-tagged IKK2 was purified as previously
described and treated with 1 mM ATP in the presence of
20 mM MgCl2 and 1 mM Na3VO4 prior to purification through a
Superdex 200 16/60 column (GE Healthcare). Protein fractions
were then concentrated in 30 kDa cutoff Amicon Ultra centrifugal
concentrators (Millipore) to the indicated concentrations. We
injected 20 mL of sample into a pre-equilibrated (20 mM Tris-Cl
pH 8, 150 mM NaCl, 5% w/v glycerol) Zenix SEC-300,
7.86300 mm column (Sepax Technologies, Inc.) at 1 mL/min.
Elution of the protein was monitored by UV-visible (Shimadzu
SPD-10A VP) and refractive index (Hitachi L-2490) detectors.
Light scattering was monitored with a Dawn–Helios multi-angle
detector (Wyatt technology). Astra VI software (Wyatt Technol-
ogy) was used to analyze light scattering data.
In Vitro Trans Auto-Phosphorylation Kinase Assay
Full-length His-tagged IKK2 and the C-terminal truncated
catalytically inactive mutant IKK2(1–665)D145N were expressed
in insect cells and purified as previously described. The two
proteins were incubated together at 30uC in the presence of
20 mM ATP in a reaction buffer containing 20 mM Tris-HCl
pH 7.5, 100 mM NaCl, 2 mM DTT, 1 mM Na3VO4, 10 mM
NaF, 20 mM b-glycerophosphate, and 10 mM PNPP. Reactions
were halted at the indicated times by adding 16Laemmli buffer
and heating the sample at 95uC for 5 min. Samples were resolved
on 8% SDS-PAGE and analyzed by immunoblot using antibody
against phospho-Ser181 of IKK2 (Cell Signaling Technology).
Fractionation by Size Exclusion Chromatography
Cytoplasmic extracts of HEK293T cells transfected with HA-
IKK2 with or without NEMO were prepared. We loaded 200 ml
of these extracts onto Superose 6 GL10/300 (GE Healthcare)
column equilibrated with 25 mM Tris pH 7.5, 150 mM NaCl,
5% glycerol, 2 mM DTT connected to an A¨KTA system. We
collected 0.5 mL fractions at a flow rate of 0.5 mL/min, and
15 mL of samples were loaded onto SDS-PAGE and analyzed by
WB using anti-HA and anti-NEMO antibodies. 3T3 cells were
stimulated with 10 ng/mL rhTNF (Roche) for 10 min. Cells were
lysed in buffer containing 10 mM HEPES, 1.5 mM MgCl2,
10 mM KCl, 0.5% NP-40, 0.5 mM DTT. We fractionated
0.5 mg of lysate with a Superose 6 GL10/300 (GE Healthcare)
column using a buffer containing 25 mM Tris pH 7.5, 150 mM
NaCl, 5% glycerol, 2 mM DTT in an A¨KTA system. 0.5 mL
fractions were collected and analyzed by western blotting using
anti-IKK2 (Millipore) or anti-NEMO (Santa Cruz Biotechnology)
antibodies.
Supporting Information
Figure S1 Primary sequence alignment of IKK subunit proteins.
Human IKK2 (hIKK2) and IKK1 (hIKK1) proteins are aligned
with murine IKK2 (mIKK2) and IKK1 (mIKK1) as well as the
IKK2 protein from Xenopus laevis (xIKK2). The human cyclic-
AMP-dependent protein kinase catalytic subunit KD (PKA) is also
included in the alignment. Each sequence is numbered and tabs
beneath stacked sequences mark every 10 amino acids in hIKK2
sequence. Identities are boxed in black, conserved positions are
dark grey, and homologous substitutions are light grey. Secondary
structure elements in the hIKK2 crystal structure are depicted as
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arrows (beta strands) and cylinders (alpha helices) above their
corresponding residues in the primary sequence and are named.
Portions of the structure for which there was no electron density
are indicated as dashed lines. The colors of the secondary structure
elements represent the three domains of hIKK2 as defined in
Figure 1A,B (KD, green; ubiquitin-like domain, cyan; scaffold
dimerization domain, magenta). Amino acid residues that
participate in interdomain interactions with the KD are indicated
by green circle, a cyan circle marks residues that contact the
ubiquitin-like domain, and magenta circles designate residues that
contact the scaffold dimerization domain (contact distance of
,4.9 A˚ as calculated from chain B). The ‘‘N’’ symbol marks amino
acid residues that are involved in dimerization (calculated from
chains B and C); ‘‘v’’ marks residues that mediate the V-shaped
interface (taken from chains A and B); ‘‘ = ’’ corresponds to
residues at the antiparallel interface (calculated from chains C and
F); and ‘‘x’’ identifies residues that contact one another at the
interface of two KDs at the crystallographic axis (taken from
chains A and D9).
(TIF)
Figure S2 (A) A portion of the hIKK2EE 2FO-FC electron
density map that covers the KD of subunit C. The model, oriented
as in Figure 2C, is shown as yellow backbone sticks and the
electron density contoured at 1.1 s is in cyan. (B) Close-up view of
the activation loop of hIKK2EE from the KD of subunit C.
Electron density contoured at 1.1 s is in cyan and the model is
shown as sticks with several side chains, including the S177E
mutation, labeled. This region is representative of the electron
density throughout the unit cell. (C) Superposition of the KDs and
key catalytic residues from hIKK2 and cAMP-dependent protein
kinase (PKA) in their active conformations. Residues that form the
‘‘hydrophobic spine’’ of PKA are depicted as space-filling spheres
(yellow for hIKK2; orange for PKA) and their numbering (bright
pink) is for PKA. Additional side chains are depicted as sticks and
labeled (purple) with hIKK2 numbering.
(TIF)
Figure S3 X-ray structure of hIKK2 from a hexagonal crystal
form. (A) The domain organization of an hIKK2 construct
containing amino acids 1–700 with serine residues 177 and 181
mutated to glutamic acid is shown schematically in comparison to
the native human protein. (B) Rigid-body refinement of the
molecular replacement solution yields an hIKK2 dimer with an
open configuration, similar to that observed in the tetragonal
crystal form. The two subunits are depicted in different shades of
green in ribbon diagram (above) and surface (below) representa-
tions. (C) Crystal packing of the hIKK2EE(1–700) in the
hexagonal crystal reveals that the dimer asymmetric unit employs
the same V-shaped and antiparallel interfaces in order to
assemble. One half of one unit cell is depicted with each of six
cyrstallographically equivalent dimers represented in different
colors. (D) Close-up view of two interacting dimers in the
hexagonal unit cell. Note the similarity in the interactions between
the two crystallographically equivalent dimers in this structure and
the four versions of a similar arrangement observed in the
tetragonal crystal form (Figure 4B).
(TIF)
Figure S4 The IKK2 oligomerization model of kinase activa-
tion. Ribbon diagram structures taken from the inactivated
Xenopus IKK2 X-ray structure (above left) and the active human
IKK2 X-ray crystal structure (others) represent different confor-
mational and oligomeric forms of IKK2 as it is converted to its
active state via opening of the dimer interface, induced proximity
with neighboring dimers, and transient oligomerization in a
conformation that promotes association between KDs and trans
auto-phosphorylation.
(TIF)
Table S1 Data collection statistics for hexagonal IKK2EE(1-
700) crystal.
(DOC)
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